BiomX Inc.
PHGE
$0.601
-$0.01-1.64%
AMEX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 32.26% | 67.23% | -3.20% | -40.08% | 7.59% |
Total Depreciation and Amortization | 107.00% | 563.56% | 469.54% | 48.14% | -12.99% |
Total Amortization of Deferred Charges | -- | -94.46% | -88.55% | -74.08% | -71.39% |
Total Other Non-Cash Items | -1,963.98% | -55,716.67% | -2,181.28% | 8,660.75% | 44.63% |
Change in Net Operating Assets | -220.88% | -332.88% | -525.06% | 58.05% | 155.92% |
Cash from Operations | -73.72% | -66.27% | -59.68% | -3.07% | 26.83% |
Capital Expenditure | 40.00% | 65.33% | 2.04% | 60.78% | 55.36% |
Sale of Property, Plant, and Equipment | 8,100.00% | -- | 1,180.00% | -80.00% | -80.00% |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -100.00% | -100.00% | -100.00% | 200.00% |
Cash from Investing | -63.35% | -79.27% | -91.47% | -93.70% | 192.60% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -152.69% | -312.12% | -706.89% | -3,379.95% | -- |
Issuance of Common Stock | -99.67% | -99.67% | -99.68% | 250.35% | 2,463.36% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 8,456.46% | 8,575.98% | 9,466.45% | -- | -- |
Cash from Financing | 1,223.70% | 786.76% | 526.80% | 3,028.28% | 892.81% |
Foreign Exchange rate Adjustments | -83.33% | 145.71% | -450.00% | -130.89% | -94.34% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 112.85% | 108.60% | 125.50% | 189.45% | 46.66% |